IP-Watch: Swiss Group Suggests Switzerland Use Compulsory Licences To Curb Cancer Drug Prices
24. May 2018
During a side event held alongside this week’s World Health Assembly, public health advocates proposed that Switzerland use compulsory licensing as a way to decrease what they said are exorbitant drug prices.
